ALZ-NET: First data collection and sharing network for new FDA-approved Alzheimer’s treatments

By | August 1, 2022
ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer’s treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time.